Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaoundé, Cameroon.
Identifieur interne : 000876 ( Main/Exploration ); précédent : 000875; suivant : 000877Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaoundé, Cameroon.
Auteurs : Catherine A. Hankins [Pays-Bas] ; Sinata Koulla-Shiro [Cameroun] ; Peter Kilmarx [États-Unis] ; Guido Ferrari [États-Unis] ; Mauro Schechter [Brésil] ; Coumba Touré Kane [Sénégal] ; François Venter [Afrique du Sud] ; Charles Ab Boucher [Pays-Bas] ; Anna-Laura Ross [France] ; Debrework Zewdie [États-Unis] ; Serge Paul Eholié ; Elly Katabira [Ouganda]Source :
- Antiviral therapy [ 2040-2058 ] ; 2017.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Agents antiVIH (synthèse chimique), Agents antiVIH (usage thérapeutique), Cameroun, Coopération internationale, Enfant, Humains, Prophylaxie pré-exposition, Prévision, Santé publique (tendances), Santé publique (économie), Syndrome d'immunodéficience acquise (), Syndrome d'immunodéficience acquise (immunologie), Syndrome d'immunodéficience acquise (virologie), Vaccins contre le SIDA (biosynthèse), Vaccins contre le SIDA (usage thérapeutique), Éradication de maladie (législation et jurisprudence).
- MESH :
- biosynthèse : Vaccins contre le SIDA.
- immunologie : Syndrome d'immunodéficience acquise.
- législation et jurisprudence : Éradication de maladie.
- synthèse chimique : Agents antiVIH.
- tendances : Santé publique.
- usage thérapeutique : Agents antiVIH, Vaccins contre le SIDA.
- virologie : Syndrome d'immunodéficience acquise.
- économie : Santé publique.
- Adolescent, Adulte, Cameroun, Coopération internationale, Enfant, Humains, Prophylaxie pré-exposition, Prévision, Syndrome d'immunodéficience acquise.
English descriptors
- KwdEn :
- AIDS Vaccines (biosynthesis), AIDS Vaccines (therapeutic use), Acquired Immunodeficiency Syndrome (immunology), Acquired Immunodeficiency Syndrome (prevention & control), Acquired Immunodeficiency Syndrome (virology), Adolescent, Adult, Anti-HIV Agents (chemical synthesis), Anti-HIV Agents (therapeutic use), Cameroon, Child, Disease Eradication (legislation & jurisprudence), Forecasting, Humans, International Cooperation, Pre-Exposure Prophylaxis, Public Health (economics), Public Health (trends).
- MESH :
- chemical , biosynthesis : AIDS Vaccines.
- chemical , chemical synthesis : Anti-HIV Agents.
- chemical , therapeutic use : AIDS Vaccines, Anti-HIV Agents.
- economics : Public Health.
- immunology : Acquired Immunodeficiency Syndrome.
- legislation & jurisprudence : Disease Eradication.
- prevention & control : Acquired Immunodeficiency Syndrome.
- trends : Public Health.
- virology : Acquired Immunodeficiency Syndrome.
- Adolescent, Adult, Cameroon, Child, Forecasting, Humans, International Cooperation, Pre-Exposure Prophylaxis.
Abstract
The underpinning theme of the 2016 INTEREST Conference held in Yaoundé, Cameroon, 3-6 May 2016 was ending AIDS as a public health threat by 2030. Focused primarily on HIV treatment, pathogenesis and prevention research in resource-limited settings, the conference attracted 369 active delegates from 34 countries, of which 22 were in Africa. Presentations on treatment optimization, acquired drug resistance, care of children and adolescents, laboratory monitoring and diagnostics, implementation challenges, HIV prevention, key populations, vaccine and cure, hepatitis C, mHealth, financing the HIV response and emerging pathogens, were accompanied by oral, mini-oral and poster presentations. Spirited plenary debates on the UNAIDS 90-90-90 treatment cascade goal and on antiretroviral pre-exposure prophylaxis took place. Joep Lange career guidance sessions and grantspersonship sessions attracted early career researchers. At the closing ceremony, the Yaoundé Declaration called on African governments; UNAIDS; development, bilateral, and multilateral partners; and civil society to adopt urgent and sustained approaches to end HIV by 2030.
DOI: 10.3851/IMP3165
PubMed: 28387654
Affiliations:
- Afrique du Sud, Brésil, Cameroun, France, Ouganda, Pays-Bas, Sénégal, États-Unis
- Caroline du Nord, Gauteng, Hollande-Méridionale, Hollande-Septentrionale, Maryland, État de New York, État de Rio de Janeiro, Île-de-France
- Amsterdam, Johannesbourg, Paris, Rio de Janeiro, Rotterdam
- Université d'Amsterdam, Université du Witwatersrand
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000658
- to stream PubMed, to step Curation: 000658
- to stream PubMed, to step Checkpoint: 000658
- to stream Ncbi, to step Merge: 004020
- to stream Ncbi, to step Curation: 004020
- to stream Ncbi, to step Checkpoint: 004020
- to stream Main, to step Merge: 000876
- to stream Main, to step Curation: 000876
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaoundé, Cameroon.</title><author><name sortKey="Hankins, Catherine A" sort="Hankins, Catherine A" uniqKey="Hankins C" first="Catherine A" last="Hankins">Catherine A. Hankins</name><affiliation wicri:level="4"><nlm:affiliation>Amsterdam Institute for Global Health and Development (AIGHD), Department of Global Health, University of Amsterdam, Amsterdam, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Amsterdam Institute for Global Health and Development (AIGHD), Department of Global Health, University of Amsterdam, Amsterdam</wicri:regionArea><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region><settlement type="city">Amsterdam</settlement></placeName><orgName type="university">Université d'Amsterdam</orgName></affiliation></author><author><name sortKey="Koulla Shiro, Sinata" sort="Koulla Shiro, Sinata" uniqKey="Koulla Shiro S" first="Sinata" last="Koulla-Shiro">Sinata Koulla-Shiro</name><affiliation wicri:level="1"><nlm:affiliation>Ministry of Health, Yaoundé, Cameroon.</nlm:affiliation><country xml:lang="fr">Cameroun</country><wicri:regionArea>Ministry of Health, Yaoundé</wicri:regionArea><wicri:noRegion>Yaoundé</wicri:noRegion></affiliation></author><author><name sortKey="Kilmarx, Peter" sort="Kilmarx, Peter" uniqKey="Kilmarx P" first="Peter" last="Kilmarx">Peter Kilmarx</name><affiliation wicri:level="2"><nlm:affiliation>National Institutes of Health, Fogarty International Center, Bethesda, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>National Institutes of Health, Fogarty International Center, Bethesda, MD</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Ferrari, Guido" sort="Ferrari, Guido" uniqKey="Ferrari G" first="Guido" last="Ferrari">Guido Ferrari</name><affiliation wicri:level="2"><nlm:affiliation>Duke University Medical Center, Department of Surgery, Durham, NC, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Duke University Medical Center, Department of Surgery, Durham, NC</wicri:regionArea><placeName><region type="state">Caroline du Nord</region></placeName></affiliation></author><author><name sortKey="Schechter, Mauro" sort="Schechter, Mauro" uniqKey="Schechter M" first="Mauro" last="Schechter">Mauro Schechter</name><affiliation wicri:level="3"><nlm:affiliation>Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.</nlm:affiliation><country xml:lang="fr">Brésil</country><wicri:regionArea>Federal University of Rio de Janeiro, Rio de Janeiro</wicri:regionArea><placeName><settlement type="city">Rio de Janeiro</settlement><region type="state">État de Rio de Janeiro</region></placeName></affiliation></author><author><name sortKey="Kane, Coumba Toure" sort="Kane, Coumba Toure" uniqKey="Kane C" first="Coumba Touré" last="Kane">Coumba Touré Kane</name><affiliation wicri:level="1"><nlm:affiliation>Laboratoire de Bacteriologie-Virologie CHU Le Dantec, Dakar University, Dakar, Senegal.</nlm:affiliation><country xml:lang="fr">Sénégal</country><wicri:regionArea>Laboratoire de Bacteriologie-Virologie CHU Le Dantec, Dakar University, Dakar</wicri:regionArea><wicri:noRegion>Dakar</wicri:noRegion></affiliation></author><author><name sortKey="Venter, Francois" sort="Venter, Francois" uniqKey="Venter F" first="François" last="Venter">François Venter</name><affiliation wicri:level="4"><nlm:affiliation>Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa.</nlm:affiliation><country xml:lang="fr">Afrique du Sud</country><wicri:regionArea>Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg</wicri:regionArea><orgName type="university">Université du Witwatersrand</orgName><placeName><settlement type="city">Johannesbourg</settlement><region type="region" nuts="2">Gauteng</region></placeName></affiliation></author><author><name sortKey="Boucher, Charles Ab" sort="Boucher, Charles Ab" uniqKey="Boucher C" first="Charles Ab" last="Boucher">Charles Ab Boucher</name><affiliation wicri:level="3"><nlm:affiliation>Erasmus Medical Center, Department of Viroscience, Rotterdam, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Erasmus Medical Center, Department of Viroscience, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Ross, Anna Laura" sort="Ross, Anna Laura" uniqKey="Ross A" first="Anna-Laura" last="Ross">Anna-Laura Ross</name><affiliation wicri:level="3"><nlm:affiliation>National Agency for AIDS Research (ANRS), Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>National Agency for AIDS Research (ANRS), Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Zewdie, Debrework" sort="Zewdie, Debrework" uniqKey="Zewdie D" first="Debrework" last="Zewdie">Debrework Zewdie</name><affiliation wicri:level="2"><nlm:affiliation>CUNY School of Public Health and Public Policy, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>CUNY School of Public Health and Public Policy, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Eholie, Serge Paul" sort="Eholie, Serge Paul" uniqKey="Eholie S" first="Serge Paul" last="Eholié">Serge Paul Eholié</name><affiliation><nlm:affiliation>CHU de Treichville, University of Abidjan, Abidjan, Ivory Coast.</nlm:affiliation><wicri:noCountry code="subField">Ivory Coast</wicri:noCountry></affiliation></author><author><name sortKey="Katabira, Elly" sort="Katabira, Elly" uniqKey="Katabira E" first="Elly" last="Katabira">Elly Katabira</name><affiliation wicri:level="1"><nlm:affiliation>Makarere University College of Health Sciences in Kampala, Kampala, Uganda.</nlm:affiliation><country xml:lang="fr">Ouganda</country><wicri:regionArea>Makarere University College of Health Sciences in Kampala, Kampala</wicri:regionArea><wicri:noRegion>Kampala</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28387654</idno><idno type="pmid">28387654</idno><idno type="doi">10.3851/IMP3165</idno><idno type="wicri:Area/PubMed/Corpus">000658</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000658</idno><idno type="wicri:Area/PubMed/Curation">000658</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000658</idno><idno type="wicri:Area/PubMed/Checkpoint">000658</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000658</idno><idno type="wicri:Area/Ncbi/Merge">004020</idno><idno type="wicri:Area/Ncbi/Curation">004020</idno><idno type="wicri:Area/Ncbi/Checkpoint">004020</idno><idno type="wicri:Area/Main/Merge">000876</idno><idno type="wicri:Area/Main/Curation">000876</idno><idno type="wicri:Area/Main/Exploration">000876</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaoundé, Cameroon.</title><author><name sortKey="Hankins, Catherine A" sort="Hankins, Catherine A" uniqKey="Hankins C" first="Catherine A" last="Hankins">Catherine A. Hankins</name><affiliation wicri:level="4"><nlm:affiliation>Amsterdam Institute for Global Health and Development (AIGHD), Department of Global Health, University of Amsterdam, Amsterdam, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Amsterdam Institute for Global Health and Development (AIGHD), Department of Global Health, University of Amsterdam, Amsterdam</wicri:regionArea><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region><settlement type="city">Amsterdam</settlement></placeName><orgName type="university">Université d'Amsterdam</orgName></affiliation></author><author><name sortKey="Koulla Shiro, Sinata" sort="Koulla Shiro, Sinata" uniqKey="Koulla Shiro S" first="Sinata" last="Koulla-Shiro">Sinata Koulla-Shiro</name><affiliation wicri:level="1"><nlm:affiliation>Ministry of Health, Yaoundé, Cameroon.</nlm:affiliation><country xml:lang="fr">Cameroun</country><wicri:regionArea>Ministry of Health, Yaoundé</wicri:regionArea><wicri:noRegion>Yaoundé</wicri:noRegion></affiliation></author><author><name sortKey="Kilmarx, Peter" sort="Kilmarx, Peter" uniqKey="Kilmarx P" first="Peter" last="Kilmarx">Peter Kilmarx</name><affiliation wicri:level="2"><nlm:affiliation>National Institutes of Health, Fogarty International Center, Bethesda, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>National Institutes of Health, Fogarty International Center, Bethesda, MD</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Ferrari, Guido" sort="Ferrari, Guido" uniqKey="Ferrari G" first="Guido" last="Ferrari">Guido Ferrari</name><affiliation wicri:level="2"><nlm:affiliation>Duke University Medical Center, Department of Surgery, Durham, NC, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Duke University Medical Center, Department of Surgery, Durham, NC</wicri:regionArea><placeName><region type="state">Caroline du Nord</region></placeName></affiliation></author><author><name sortKey="Schechter, Mauro" sort="Schechter, Mauro" uniqKey="Schechter M" first="Mauro" last="Schechter">Mauro Schechter</name><affiliation wicri:level="3"><nlm:affiliation>Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.</nlm:affiliation><country xml:lang="fr">Brésil</country><wicri:regionArea>Federal University of Rio de Janeiro, Rio de Janeiro</wicri:regionArea><placeName><settlement type="city">Rio de Janeiro</settlement><region type="state">État de Rio de Janeiro</region></placeName></affiliation></author><author><name sortKey="Kane, Coumba Toure" sort="Kane, Coumba Toure" uniqKey="Kane C" first="Coumba Touré" last="Kane">Coumba Touré Kane</name><affiliation wicri:level="1"><nlm:affiliation>Laboratoire de Bacteriologie-Virologie CHU Le Dantec, Dakar University, Dakar, Senegal.</nlm:affiliation><country xml:lang="fr">Sénégal</country><wicri:regionArea>Laboratoire de Bacteriologie-Virologie CHU Le Dantec, Dakar University, Dakar</wicri:regionArea><wicri:noRegion>Dakar</wicri:noRegion></affiliation></author><author><name sortKey="Venter, Francois" sort="Venter, Francois" uniqKey="Venter F" first="François" last="Venter">François Venter</name><affiliation wicri:level="4"><nlm:affiliation>Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa.</nlm:affiliation><country xml:lang="fr">Afrique du Sud</country><wicri:regionArea>Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg</wicri:regionArea><orgName type="university">Université du Witwatersrand</orgName><placeName><settlement type="city">Johannesbourg</settlement><region type="region" nuts="2">Gauteng</region></placeName></affiliation></author><author><name sortKey="Boucher, Charles Ab" sort="Boucher, Charles Ab" uniqKey="Boucher C" first="Charles Ab" last="Boucher">Charles Ab Boucher</name><affiliation wicri:level="3"><nlm:affiliation>Erasmus Medical Center, Department of Viroscience, Rotterdam, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Erasmus Medical Center, Department of Viroscience, Rotterdam</wicri:regionArea><placeName><settlement type="city">Rotterdam</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Ross, Anna Laura" sort="Ross, Anna Laura" uniqKey="Ross A" first="Anna-Laura" last="Ross">Anna-Laura Ross</name><affiliation wicri:level="3"><nlm:affiliation>National Agency for AIDS Research (ANRS), Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>National Agency for AIDS Research (ANRS), Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Zewdie, Debrework" sort="Zewdie, Debrework" uniqKey="Zewdie D" first="Debrework" last="Zewdie">Debrework Zewdie</name><affiliation wicri:level="2"><nlm:affiliation>CUNY School of Public Health and Public Policy, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>CUNY School of Public Health and Public Policy, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Eholie, Serge Paul" sort="Eholie, Serge Paul" uniqKey="Eholie S" first="Serge Paul" last="Eholié">Serge Paul Eholié</name><affiliation><nlm:affiliation>CHU de Treichville, University of Abidjan, Abidjan, Ivory Coast.</nlm:affiliation><wicri:noCountry code="subField">Ivory Coast</wicri:noCountry></affiliation></author><author><name sortKey="Katabira, Elly" sort="Katabira, Elly" uniqKey="Katabira E" first="Elly" last="Katabira">Elly Katabira</name><affiliation wicri:level="1"><nlm:affiliation>Makarere University College of Health Sciences in Kampala, Kampala, Uganda.</nlm:affiliation><country xml:lang="fr">Ouganda</country><wicri:regionArea>Makarere University College of Health Sciences in Kampala, Kampala</wicri:regionArea><wicri:noRegion>Kampala</wicri:noRegion></affiliation></author></analytic><series><title level="j">Antiviral therapy</title><idno type="eISSN">2040-2058</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS Vaccines (biosynthesis)</term><term>AIDS Vaccines (therapeutic use)</term><term>Acquired Immunodeficiency Syndrome (immunology)</term><term>Acquired Immunodeficiency Syndrome (prevention & control)</term><term>Acquired Immunodeficiency Syndrome (virology)</term><term>Adolescent</term><term>Adult</term><term>Anti-HIV Agents (chemical synthesis)</term><term>Anti-HIV Agents (therapeutic use)</term><term>Cameroon</term><term>Child</term><term>Disease Eradication (legislation & jurisprudence)</term><term>Forecasting</term><term>Humans</term><term>International Cooperation</term><term>Pre-Exposure Prophylaxis</term><term>Public Health (economics)</term><term>Public Health (trends)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Agents antiVIH (synthèse chimique)</term><term>Agents antiVIH (usage thérapeutique)</term><term>Cameroun</term><term>Coopération internationale</term><term>Enfant</term><term>Humains</term><term>Prophylaxie pré-exposition</term><term>Prévision</term><term>Santé publique (tendances)</term><term>Santé publique (économie)</term><term>Syndrome d'immunodéficience acquise ()</term><term>Syndrome d'immunodéficience acquise (immunologie)</term><term>Syndrome d'immunodéficience acquise (virologie)</term><term>Vaccins contre le SIDA (biosynthèse)</term><term>Vaccins contre le SIDA (usage thérapeutique)</term><term>Éradication de maladie (législation et jurisprudence)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en"><term>AIDS Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en"><term>Anti-HIV Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>AIDS Vaccines</term><term>Anti-HIV Agents</term></keywords><keywords scheme="MESH" qualifier="biosynthèse" xml:lang="fr"><term>Vaccins contre le SIDA</term></keywords><keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Public Health</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Syndrome d'immunodéficience acquise</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Acquired Immunodeficiency Syndrome</term></keywords><keywords scheme="MESH" qualifier="legislation & jurisprudence" xml:lang="en"><term>Disease Eradication</term></keywords><keywords scheme="MESH" qualifier="législation et jurisprudence" xml:lang="fr"><term>Éradication de maladie</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Acquired Immunodeficiency Syndrome</term></keywords><keywords scheme="MESH" qualifier="synthèse chimique" xml:lang="fr"><term>Agents antiVIH</term></keywords><keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Santé publique</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Public Health</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Agents antiVIH</term><term>Vaccins contre le SIDA</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Syndrome d'immunodéficience acquise</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Acquired Immunodeficiency Syndrome</term></keywords><keywords scheme="MESH" qualifier="économie" xml:lang="fr"><term>Santé publique</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Cameroon</term><term>Child</term><term>Forecasting</term><term>Humans</term><term>International Cooperation</term><term>Pre-Exposure Prophylaxis</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Cameroun</term><term>Coopération internationale</term><term>Enfant</term><term>Humains</term><term>Prophylaxie pré-exposition</term><term>Prévision</term><term>Syndrome d'immunodéficience acquise</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The underpinning theme of the 2016 INTEREST Conference held in Yaoundé, Cameroon, 3-6 May 2016 was ending AIDS as a public health threat by 2030. Focused primarily on HIV treatment, pathogenesis and prevention research in resource-limited settings, the conference attracted 369 active delegates from 34 countries, of which 22 were in Africa. Presentations on treatment optimization, acquired drug resistance, care of children and adolescents, laboratory monitoring and diagnostics, implementation challenges, HIV prevention, key populations, vaccine and cure, hepatitis C, mHealth, financing the HIV response and emerging pathogens, were accompanied by oral, mini-oral and poster presentations. Spirited plenary debates on the UNAIDS 90-90-90 treatment cascade goal and on antiretroviral pre-exposure prophylaxis took place. Joep Lange career guidance sessions and grantspersonship sessions attracted early career researchers. At the closing ceremony, the Yaoundé Declaration called on African governments; UNAIDS; development, bilateral, and multilateral partners; and civil society to adopt urgent and sustained approaches to end HIV by 2030.</div></front></TEI><affiliations><list><country><li>Afrique du Sud</li><li>Brésil</li><li>Cameroun</li><li>France</li><li>Ouganda</li><li>Pays-Bas</li><li>Sénégal</li><li>États-Unis</li></country><region><li>Caroline du Nord</li><li>Gauteng</li><li>Hollande-Méridionale</li><li>Hollande-Septentrionale</li><li>Maryland</li><li>État de New York</li><li>État de Rio de Janeiro</li><li>Île-de-France</li></region><settlement><li>Amsterdam</li><li>Johannesbourg</li><li>Paris</li><li>Rio de Janeiro</li><li>Rotterdam</li></settlement><orgName><li>Université d'Amsterdam</li><li>Université du Witwatersrand</li></orgName></list><tree><noCountry><name sortKey="Eholie, Serge Paul" sort="Eholie, Serge Paul" uniqKey="Eholie S" first="Serge Paul" last="Eholié">Serge Paul Eholié</name></noCountry><country name="Pays-Bas"><region name="Hollande-Septentrionale"><name sortKey="Hankins, Catherine A" sort="Hankins, Catherine A" uniqKey="Hankins C" first="Catherine A" last="Hankins">Catherine A. Hankins</name></region><name sortKey="Boucher, Charles Ab" sort="Boucher, Charles Ab" uniqKey="Boucher C" first="Charles Ab" last="Boucher">Charles Ab Boucher</name></country><country name="Cameroun"><noRegion><name sortKey="Koulla Shiro, Sinata" sort="Koulla Shiro, Sinata" uniqKey="Koulla Shiro S" first="Sinata" last="Koulla-Shiro">Sinata Koulla-Shiro</name></noRegion></country><country name="États-Unis"><region name="Maryland"><name sortKey="Kilmarx, Peter" sort="Kilmarx, Peter" uniqKey="Kilmarx P" first="Peter" last="Kilmarx">Peter Kilmarx</name></region><name sortKey="Ferrari, Guido" sort="Ferrari, Guido" uniqKey="Ferrari G" first="Guido" last="Ferrari">Guido Ferrari</name><name sortKey="Zewdie, Debrework" sort="Zewdie, Debrework" uniqKey="Zewdie D" first="Debrework" last="Zewdie">Debrework Zewdie</name></country><country name="Brésil"><region name="État de Rio de Janeiro"><name sortKey="Schechter, Mauro" sort="Schechter, Mauro" uniqKey="Schechter M" first="Mauro" last="Schechter">Mauro Schechter</name></region></country><country name="Sénégal"><noRegion><name sortKey="Kane, Coumba Toure" sort="Kane, Coumba Toure" uniqKey="Kane C" first="Coumba Touré" last="Kane">Coumba Touré Kane</name></noRegion></country><country name="Afrique du Sud"><region name="Gauteng"><name sortKey="Venter, Francois" sort="Venter, Francois" uniqKey="Venter F" first="François" last="Venter">François Venter</name></region></country><country name="France"><region name="Île-de-France"><name sortKey="Ross, Anna Laura" sort="Ross, Anna Laura" uniqKey="Ross A" first="Anna-Laura" last="Ross">Anna-Laura Ross</name></region></country><country name="Ouganda"><noRegion><name sortKey="Katabira, Elly" sort="Katabira, Elly" uniqKey="Katabira E" first="Elly" last="Katabira">Elly Katabira</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000876 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000876 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaSubSaharaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:28387654
|texte= Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaoundé, Cameroon.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:28387654" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SidaSubSaharaV1
| This area was generated with Dilib version V0.6.32. |  |